These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 35254660)

  • 41. Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm.
    Boni C; Cavazzini D; Bolchi A; Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Ferrari C; Ottonello S
    Front Immunol; 2021; 12():730051. PubMed ID: 34566990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients.
    Asplund Högelin K; Ruffin N; Pin E; Hober S; Nilsson P; Starvaggi Cucuzza C; Khademi M; Olsson T; Piehl F; Al Nimer F
    Eur J Neurol; 2022 Nov; 29(11):3317-3328. PubMed ID: 35808856
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination.
    Davenport BJ; Morrison TE; Kedl RM; Klarquist J
    J Immunol; 2021 Jun; 206(11):2503-2507. PubMed ID: 33972373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273.
    Verstegen NJM; Hagen RR; van den Dijssel J; Kuijper LH; Kreher C; Ashhurst T; Kummer LYL; Steenhuis M; Duurland M; de Jongh R; de Jong N; van der Schoot CE; Bos AV; Mul E; Kedzierska K; van Dam KPJ; Stalman EW; Boekel L; Wolbink G; Tas SW; Killestein J; van Kempen ZLE; Wieske L; Kuijpers TW; Eftimov F; Rispens T; van Ham SM; Ten Brinke A; van de Sandt CE;
    Elife; 2022 Jul; 11():. PubMed ID: 35838348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B- and T-cell immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing-home residents.
    Torres I; Albert E; Giménez E; Alcaraz MJ; Botija P; Amat P; Remigia MJ; Beltrán MJ; Rodado C; Huntley D; Olea B; Navarro D
    Clin Microbiol Infect; 2021 Nov; 27(11):1672-1677. PubMed ID: 34174397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2.
    Thomas Κ; Grigoropoulos I; Alexopoulou P; Karofylakis E; Galani I; Papadopoulou KK; Tsiavou A; Ntourou A; Mavrou E; Qevani I; Katsimbri P; Koutsianas C; Mavrea E; Vassilopoulos D; Pournaras S; Tsiodras S; Boumpas D; Antoniadou A
    Rheumatology (Oxford); 2024 Feb; 63(2):534-541. PubMed ID: 37228039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab.
    Tolf A; Wiberg A; Müller M; Nazir FH; Pavlovic I; Laurén I; Mangsbo S; Burman J
    JAMA Netw Open; 2022 May; 5(5):e2211497. PubMed ID: 35544139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy.
    Bazzi SA; Maguire C; Holay N; Geltman J; Hurley K; DiPasquale C; Abigania M; Olson E; Ehrlich LIR; Triplett TA; Melamed E
    Mult Scler Relat Disord; 2022 Dec; 68():104195. PubMed ID: 36223705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rituximab-to-vaccine interval on SARS-CoV-2 immunogenicity in children: The potential role of prior natural infection.
    Gualtieri R; Yerly S; Garcia-Tarodo S; Parvex P; Rock N; Posfay-Barbe K; Didierlaurent AM; Eberhardt C; Blanchard-Rohner G
    Pediatr Allergy Immunol; 2024 May; 35(5):e14161. PubMed ID: 38796784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microfluidic antibody profiling after repeated SARS-CoV-2 vaccination links antibody affinity and concentration to impaired immunity and variant escape in patients on anti-CD20 therapy.
    Priddey A; Chen-Xu MXH; Cooper DJ; MacMillan S; Meisl G; Xu CK; Hosmillo M; Goodfellow IG; Kollyfas R; Doffinger R; Bradley JR; Mohorianu II; Jones R; Knowles TPJ; Smith R; Kosmoliaptsis V
    Front Immunol; 2023; 14():1296148. PubMed ID: 38259440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients.
    Schietzel S; Anderegg M; Limacher A; Born A; Horn MP; Maurer B; Hirzel C; Sidler D; Moor MB
    RMD Open; 2022 Feb; 8(1):. PubMed ID: 35115385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.
    Iannetta M; Landi D; Cola G; Campogiani L; Malagnino V; Teti E; Coppola L; Di Lorenzo A; Fraboni D; Buccisano F; Grelli S; Mozzani M; Zingaropoli MA; Ciardi MR; Nisini R; Bernardini S; Andreoni M; Marfia GA; Sarmati L
    Front Immunol; 2021; 12():796482. PubMed ID: 35111162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2-Specific and Functional Cytotoxic CD8 Cells in Primary Antibody Deficiency: Natural Infection and Response to Vaccine.
    Gupta S; Agrawal S; Sandoval A; Su H; Tran M; Demirdag Y
    J Clin Immunol; 2022 Jul; 42(5):914-922. PubMed ID: 35366743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses.
    Nathan A; Rossin EJ; Kaseke C; Park RJ; Khatri A; Koundakjian D; Urbach JM; Singh NK; Bashirova A; Tano-Menka R; Senjobe F; Waring MT; Piechocka-Trocha A; Garcia-Beltran WF; Iafrate AJ; Naranbhai V; Carrington M; Walker BD; Gaiha GD
    Cell; 2021 Aug; 184(17):4401-4413.e10. PubMed ID: 34265281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.
    Ma Y; Liu F; Lin T; Chen L; Jiang A; Tian G; Nielsen M; Wang M
    J Infect Dis; 2021 Sep; 224(6):956-966. PubMed ID: 34145459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy.
    Sidler D; Born A; Schietzel S; Horn MP; Aeberli D; Amsler J; Möller B; Njue LM; Medri C; Angelillo-Scherrer A; Borradori L; Seyed Jafari SM; Radonjic-Hoesli S; Chan A; Hoepner R; Bacher U; Mani LY; Iype JM; Suter-Riniker F; Staehelin C; Nagler M; Hirzel C; Maurer B; Moor MB
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35361691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19.
    Zonozi R; Walters LC; Shulkin A; Naranbhai V; Nithagon P; Sauvage G; Kaeske C; Cosgrove K; Nathan A; Tano-Menka R; Gayton AC; Getz MA; Senjobe F; Worrall D; Iafrate AJ; Fromson C; Montesi SB; Rao DA; Sparks JA; Wallace ZS; Farmer JR; Walker BD; Charles RC; Laliberte K; Niles JL; Gaiha GD
    Sci Transl Med; 2023 Nov; 15(724):eadh4529. PubMed ID: 38019932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
    Joag V; Wijeyesinghe S; Stolley JM; Quarnstrom CF; Dileepan T; Soerens AG; Sangala JA; O'Flanagan SD; Gavil NV; Hong SW; Bhela S; Gangadhara S; Weyu E; Matchett WE; Thiede J; Krishna V; Cheeran MC; Bold TD; Amara R; Southern P; Hart GT; Schifanella L; Vezys V; Jenkins MK; Langlois RA; Masopust D
    J Immunol; 2021 Mar; 206(5):931-935. PubMed ID: 33441437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.